
1. science. 2018 jan 5;359(6371):48-55. doi: 10.1126/science.aan1078.

transferrin receptor 1 reticulocyte-specific receptor plasmodium vivax.

gruszczyk j(1), kanjee u(2), chan lj(1)(3), menant s(1), malleret b(4)(5), lim
nty(1), schmidt cq(6), mok yf(7), lin km(8), pearson rd(9)(10), rangel g(2),
smith bj(11), call mj(1)(3), weekes mp(8), griffin mdw(7), murphy jm(1)(3),
abraham j(12), sriprawat k(13), menezes mj(14), ferreira mu(14), russell b(15),
renia l(5), duraisingh mt(2), tham wh(1)(3).

author information: 
(1)the walter eliza hall institute medical research, parkville, victoria
3052, australia.
(2)department immunology infectious diseases, harvard t. h. chan school of
public health, boston, 02115, usa.
(3)department medical biology, university melbourne, melbourne,
victoria 3010, australia.
(4)department microbiology immunology, yong loo lin school medicine,
national university singapore, 117597 singapore.
(5)singapore immunology network, a*star, 138648 singapore.
(6)institute pharmacology natural products clinical pharmacology, ulm
university, germany.
(7)department biochemistry molecular biology, bio21 molecular science 
biotechnology institute, university melbourne, melbourne, victoria 3010,
australia.
(8)cambridge institute medical research, cambridge cb2 oxy, uk.
(9)wellcome trust sanger institute, hinxton, cambridge, uk.
(10)big data institute, li ka shing centre health information discovery, 
oxford, uk.
(11)la trobe institute molecular science, la trobe university, melbourne,
victoria 3086, australia.
(12)department microbiology immunobiology, harvard medical school, boston,
ma 02115, usa.
(13)shoklo malaria research unit, mahidol-oxford tropical medicine research unit,
faculty tropical medicine, mahidol university, mae sot, thailand.
(14)department parasitology, institute biomedical sciences, university of
são paulo, são paulo, brazil.
(15)department microbiology immunology, university otago, dunedin 9054,
new zealand.

plasmodium vivax shows strict host tropism reticulocytes. identified
transferrin receptor 1 (tfr1) receptor p. vivax reticulocyte-binding
protein 2b (pvrbp2b). determined structure n-terminal domain of
pvrbp2b involved red blood cell binding, elucidating molecular basis for
tfr1 recognition. validated tfr1 biological target pvrbp2b
engagement means tfr1 expression knockdown analysis. tfr1 mutant cells
deficient pvrbp2b binding refractory invasion p. vivax to
invasion p. falciparum using brazilian thai clinical isolates, show
that pvrbp2b monoclonal antibodies inhibit reticulocyte binding also block
p. vivax entry reticulocytes. data show tfr1-pvrbp2b invasion
pathway critical recognition reticulocytes p. vivax
invasion.

copyright © 2018, american association advancement science.

doi: 10.1126/science.aan1078 
pmcid: pmc5788258
pmid: 29302006  [indexed medline]

